Timothy Cannon, MD, Associate Professor at University of Virginia Medical School

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    sirtex
    Topic:
    y90
    Date added:
    02/05/2025
    Date updated:
    01/13/2026
    Relationship end date:
    02/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    revolution medicine
    Topic:
    advisory board
    Date added:
    01/13/2026
    Date updated:
    01/13/2026
    Relationship end date:
    05/10/2025
Return to 2026 Inova Fairfax Molecular Tumor Board